Oncology Institute Stock Price on December 18, 2024
| TOI Stock | USD 0.21 0.02 10.53% |
Below is the normalized historical share price chart for Oncology Institute extending back to June 04, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncology Institute stands at 0.21, as last reported on the 22nd of December, with the highest price reaching 0.23 and the lowest price hitting 0.19 during the day.
If you're considering investing in Oncology Stock, it is important to understand the factors that can impact its price. Oncology Institute maintains Sharpe Ratio (i.e., Efficiency) of -0.0212, which implies the firm had a -0.0212% return per unit of risk over the last 3 months. Oncology Institute exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncology Institute's Risk Adjusted Performance of (0.01), variance of 62.7, and Coefficient Of Variation of (4,754) to confirm the risk estimate we provide.
The Oncology Institute's current Total Stockholder Equity is estimated to increase to about 78.4 M, while Common Stock Shares Outstanding is projected to decrease to under 68.4 M. . The current Price To Sales Ratio is estimated to decrease to 0.44. The current Price Earnings Ratio is estimated to decrease to -1.9. Oncology Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of November 2021 | 200 Day MA 0.5979 | 50 Day MA 0.2479 | Beta 0.616 |
Oncology |
Sharpe Ratio = -0.0212
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TOI |
Estimated Market Risk
| 7.98 actual daily | 71 71% of assets are less volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oncology Institute is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncology Institute by adding Oncology Institute to a well-diversified portfolio.
Price Book 1.0254 | Enterprise Value Ebitda (1.87) | Price Sales 0.044 | Shares Float 45.9 M | Wall Street Target Price 2 |
Oncology Institute Main Headline on 18th of December 2024
Florida Blue enhances cancer care for thousands of members by gurufocus.com
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care JACKSONVILLE
Oncology Institute Valuation on December 18, 2024
It is possible to determine the worth of Oncology Institute on a given historical date. On December 18, 2024 Oncology was worth 0.2 at the beginning of the trading date compared to the closed value of 0.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncology Institute stock. Still, in general, we apply an absolute valuation method to find Oncology Institute's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncology Institute where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncology Institute's related companies.
| Open | High | Low | Close | Volume | |
| 0.19 | 0.20 | 0.17 | 0.19 | 761,919 | |
12/18/2024 | 0.20 | 0.20 | 0.18 | 0.19 | 528,515 |
| 0.19 | 0.21 | 0.18 | 0.21 | 1,297,489 |
| Backtest Oncology Institute | | | Oncology Institute History | | | Oncology Institute Valuation | Previous | Next |
Oncology Institute Trading Date Momentum on December 18, 2024
| On December 19 2024 Oncology Institute was traded for 0.21 at the closing time. Highest Oncology Institute's price during the trading hours was 0.21 and the lowest price during the day was 0.18 . The net volume was 1.3 M. The overall trading history on the 19th of December contributed to the next trading period price growth. The trading price change to the next next day price was 10.53% . The trading delta at closing time to current price is 21.05% . |
Oncology Institute Fundamentals Correlations and Trends
By evaluating Oncology Institute's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncology financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncology Institute Stock history
Oncology Institute investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncology is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncology Institute will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncology Institute stock prices may prove useful in developing a viable investing in Oncology Institute
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73.7 M | 68.4 M | |
| Net Income Applicable To Common Shares | 61.2 K | 64.3 K |
Oncology Institute Quarterly Net Working Capital |
|
Oncology Institute Stock Technical Analysis
Oncology Institute technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oncology Institute Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Oncology Institute cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncology Institute December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns
Oncology Institute Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncology Institute's price direction in advance. Along with the technical and fundamental analysis of Oncology Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncology to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.10) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Oncology Stock analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |